Delisting risk
PRPH · NASDAQ · Medical - Pharmaceuticals

ProPhase Labs

Operator of whole-genome sequencing, esophageal diagnostics, and OTC supplement brands.

$0.0211
After-hours close0.00 (0.00%)
At close$0.0211(−0.00%)
DateEstimateReportedSurprise
Nov 2026
Aug 2026−$0.22
Jul 2026
Jun 2026−$0.43
Jun 2026−$1.20−$0.87+27.5%
Jun 2026

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026
Jun 2026−$1.20
Jun 2026
May 2026−$1.20
Apr 2026
Nov 2025
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 16, 2026
Aug 19, 2026−$0.22$1.0M
Jul 1, 2026$478.0K
Jun 30, 2026−$0.43$478.0K
Jun 24, 2026−$1.20−$0.87+27.5%$9.7M$784.0K−91.9%
Jun 23, 2026

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
Jun 22, 2026
Jun 18, 2026
Jun 16, 2026
Jun 15, 2026
Jun 11, 2026
Jun 10, 2026
Jun 9, 2026
Jun 8, 2026
Jun 4, 2026
Jun 3, 2026
Jun 2, 2026−$1.20$9.7M
Jun 1, 2026
May 28, 2026−$1.20$9.7M
Apr 14, 2026
Nov 19, 2025
Aug 13, 2025
May 20, 2025
Mar 31, 2025
Nov 13, 2024
Aug 14, 2024
May 9, 2024
Mar 15, 2024
Nov 9, 2023
Aug 10, 2023
May 11, 2023
Mar 28, 2023
Nov 10, 2022
Aug 11, 2022
May 13, 2022
Mar 30, 2022
Nov 12, 2021
Aug 13, 2021
May 13, 2021
Mar 31, 2021
Nov 16, 2020
Aug 11, 2020
May 12, 2020
Mar 26, 2020
Nov 12, 2019
Aug 12, 2019